Quarterly report pursuant to Section 13 or 15(d)

Marketable Securities - Schedule of Marketable Securities (Detail)

v3.20.2
Marketable Securities - Schedule of Marketable Securities (Detail) - Corporate Debt [Member]
Sep. 30, 2020
USD ($)
Schedule of Available-for-sale Securities [Line Items]  
Marketable Securities, Amortized Cost $ 32,091,015
Marketable Securities, Unrealized Gains 7,005
Marketable Securities, Unrealized Losses (15,311)
Marketable Securities, Fair Value $ 32,082,709